LIPEMIA RETINALIS DURING CHEMOTHERAPY WITH ADJUNCTIVE GLUCOCORTICOID TREATMENT IN A PATIENT WITH COLON CARCINOMA. Issue Volume 15:Issues 4(2021) (July 2021)

• Record Type: Journal Article
• Authors: Wetzel, Barbara; Mylonas, Georgios; Puntus, Thomas; Prager, Franz; Bernhart, Clemens; Amon, Michael
• Is Part Of: Retinal cases & brief reports. Volume 15:Issues 4(2021)
• Publication Date: 2021-07
• Subjects: chemotherapy -- colon carcinoma -- cortisone -- hyperlipidemia -- lipemia retinalis; Retina -- Diseases -- Periodicals; Retina -- Periodicals; Retinal Diseases -- Periodicals; Retina -- Case Reports; Retinal Diseases -- Case Reports; 617.7
• DOI: 10.1097/ICB.0000000000000814
• Languages: English
• ISSNs: 1935-1089

Abstract

Abstract : Purpose: The purpose of this report is to describe a case of lipemia retinalis due to decompensating hyperlipidemia that occurred during chemotherapy in a patient with metastatic colon carcinoma. Methods: Retrospective case report. Results: A 55-year-old non–insulin-dependent diabetic man with well-controlled hyperlipidemia presented himself with temporarily blurred vision in both eyes occurring during chemotherapy. He was found to have lipemia retinalis in his both eyes. Blood tests revealed elevated cholesterol and triglyceride levels exceeding 8, 200 mg/dL. He received six cycles of FOLFIRI/bevacizumab and accompanying dexamethasone because of colon cancer with pulmonary metastases. Lipemia retinalis had resolved after a 6-week follow-up when chemotherapy was finished, and the patients' triglyceride and glucose levels decreased to normal values. Conclusion: Lipemia retinalis associated with visual impairment may occur during chemotherapy under accompanying treatment with dexamethasone. Even if patients with hyperlipidemia are metabolically well-controlled with oral medication, treatment with dexamethasone can potentially lead to decompensation of hyperlipidemia causing secondary lipemia retinalis. Abstract : We report the case of a 55-year-old non–insulin-dependent diabetic man with well-controlled hyperlipidemia who presented himself with temporarily blurred vision in both eyes occurring during chemotherapy with adjunctive glucocorticoid treatment for colon carcinoma. Fundus examination revealed lipemia retinalis in his both eyes that resolved after 6 weeks when the chemotherapy was finished, and the patients' triglyceride and glucose levels decreased.